Studying the Anion Gap to Predict Major Heart Problems After Primary Percutaneous Coronary Intervention in Adults with ST-Segment Elevation Myocardial Infarction

What this Trial Is About

Researchers are evaluating the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients diagnosed with ST-segment elevation myocardial infarction STEMI. This observational study collects secondary data from hospital records of inpatients who underwent primary percutaneous coronary intervention PPCI for STEMI. The data includes demographic information, clinical presentation, laboratory results, and angiography findings, which are analyzed using IBM SPSS Statistics v26. The study involves measuring the anion gap through blood examination before PPCI as a diagnostic test. Patients are grouped based on whether they suffered major adverse cardiovascular events MACE after the procedure. The research focuses on the relationship between initial anion gap levels and subsequent cardiovascular complications during hospitalization. Participants information is gathered from hospital registries by reviewing medical records. Researchers track the occurrence of MACE and other outcomes such as mortality, reinfarction, stroke, lethal arrhythmia, acute lung oedema, and cardiogenic shock during the hospital stay, up to one week. The study helps to understand how anion gap values relate to these serious events in STEMI patients treated with PPCI.

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction